SEARCH

SEARCH BY CITATION

References

  • Aldinucci, D., Lorenzon, D., Cattaruzza, L., Pinto, A., Gloghini, A., Carbone, A. & Colombatti, A. (2008) Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. International Journal of Cancer, 122, 769776.
  • Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., Zagonel, V. & Pinto, A. (1995) Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin’s disease cell lines. Blood, 85, 780789.
  • Carbone, A., Gloghini, A., Larocca, L.M., Capello, D., Pierconti, F., Canzonieri, V., Tirelli, U., Dalla-Favera, R. & Gaidano, G. (2001) Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood, 97, 744751.
  • Carbone, A., Gloghini, A., Aldinucci, D., Gattei, V., Dalla-Favera, R. & Gaidano, G. (2002) Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. British Journal of Haematology, 117, 366372.
  • Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali-Tanci, L., Ugolini, B., Sebastiani, C., Cattoretti, G., Pileri, S., Dalla-Favera, R. & Stein, H. (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood, 95, 20842092.
  • Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K. & Dalla-Favera, R. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nature Immunology, 7, 773782.
  • Küppers, R. (2009) The biology of Hodgkin’s lymphoma. Nature Reviews Cancer, 9, 1527.
  • Re, D., Hofmann, A., Wolfe, J., Diehl, V. & Staratschek-Jox, A. (2000) Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95. Experimental Hematology, 28, 3135.
  • Saito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P.M., Bhagat, G., Pernis, A., Pasqualucci, L. & Dalla-Favera, R. (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell, 12, 280292.
  • Shaffer, A.L., Emre, N.C., Romesser, P.B. & Staudt, L.M. (2009) IRF4: Immunity Malignancy! Therapy? Clinical Cancer Research, 15, 29542961.
  • Skinnider, B.F. & Mak, T.W. (2002) The role of cytokines in classical Hodgkin lymphoma. Blood, 99, 42834297.
  • Tamura, T., Tailor, P., Yamaoka, K., Kong, H.J., Tsujimura, H., O’Shea, J.J., Singh, H. & Ozato, K. (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. Journal of Immunology, 174, 25732581.
  • Valsami, S., Pappa, V., Rontogianni, D., Kontsioti, F., Papageorgiou, E., Dervenoulas, J., Karmiris, T., Papageorgiou, S., Harhalakis, N., Xiros, N., Nikiforakis, E. & Economopoulos, T. (2007) A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin’s lymphoma: a potential prognostic role of MUM1/IRF4. Haematologica, 92, 13431350.
  • Verdelli, D., Nobili, L., Todoerti, K., Intini, D., Cosenza, M., Civallero, M., Bertacchini, J., Deliliers, G.L., Sacchi, S., Lombardi, L. & Neri, A. (2009) Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression. Hematological Oncology, 27, 2330.
  • Xu, D., Zhao, L., Del Valle, L., Miklossy, J. & Zhang, L. (2008) Interferon regulatory factor 4 is involved in Epstein–Barr virus-mediated transformation of human B lymphocytes. Journal of Virology, 82, 62516258.